Capsular PolysaccharideSegment Held Largest Share of Typhoid Fever Vaccines Marketduring forecast period

According to a new market research study of “South and Central AmericaTyphoid Fever Vaccines MarketForecast to 2027 - Covid-19 Impact and AnalysisbyVaccine Type and Route Of Administration,”South and Central Americatyphoid fever vaccines marketis projectedto reach US$ US$ 24.37 million in 2027 from US$ 13.79 million. The market is estimated to grow at CAGR of 7.7% from 2020 to 2027. The report highlights trends prevailing in the South and Central Americatyphoid fever vaccines market and the factors driving market along with those that act as hindrances.

The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others.The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.

South and Central Americatyphoid fever vaccines market is expected to grow owing to key prevalence of typhoid in the region, and poor sanitation facilities. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.

Leading companies operating in the South and Central Americatyphoid fever vaccines marketare GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., Sanofi, Pax Vax Inc, BHARAT BIOTECH among others.

South and Central AmericaTyphoid Fever Vaccines Market, By Country, 2019 (% share)

The report segments South and Central AmericaTyphoid Fever Vaccines market as follows:

ByVaccine Type

• Live Attenuated Vaccine
• Capsular Polysaccharide Vaccines
• Conjugate Vaccine
• Others

By Route of Administration

• Oral
• Injectable

By Country

• Brazil
• Argentina
• Rest of South and Central America